Medicine and Dentistry
Patient
100%
Non Small Cell Lung Cancer
100%
Epidermal Growth Factor Receptor
100%
Erlotinib
100%
Medicare
37%
Medicaid
37%
Survival
37%
Age
25%
Male
25%
Gender
25%
Health
12%
Therapeutic Procedure
12%
Malignant Neoplasm
12%
Cancer Registry
12%
Drug
12%
Regression Analysis
12%
Personalized Medicine
12%
Smoking
12%
Disparity
12%
Proportional Hazards Model
12%
Logistic Regression Analysis
12%
Survival Analysis
12%
ICD-9
12%
Procedure Code
12%
Nursing and Health Professions
Patient
100%
Non Small Cell Lung Cancer
100%
Erlotinib
100%
Epidermal Growth Factor Receptor
100%
Medicare
37%
Medicaid
37%
Survival
37%
Gender
25%
Male
25%
Procedures
12%
Survival Analysis
12%
Drug
12%
Malignant Neoplasm
12%
Personalized Medicine
12%
Logistic Regression Analysis
12%
Proportional Hazards Model
12%
Regression Analysis
12%
ICD-9
12%
Cancer Registry
12%
Biochemistry, Genetics and Molecular Biology
Erlotinib
100%
Epidermal Growth Factor Receptor
100%
Survival
50%
Age
25%
Gender
25%
Cancer Registry
12%
Health
12%
Smoking
12%
ICD-9
12%